Jeremy Li, Director of Data Science - Jul 26, 2023

Gencove platform update offers phased genotypes, improved imputation of sex chromosomes and faster processing times

Staying at the cutting-edge of the latest bioinformatic tooling is critical to navigating the dynamic landscape of genomics. We are pleased to announce several new optimizations and improvements to our standard pipeline offerings that will reduce processing time and resources.

Read More >

Jesse Hoff, Agrigenomics Product Manager - Jul 10, 2023

Exploring the power of low-pass WGS with target capture in plant breeding

Gencove and Twist Biosciences have partnered to pressure test the utility of lp-WGS plus target capture and imputation for a major crop species, soybeans, demonstrating that lp-WGS with target capture works well in plants and covers a large panel.

Read More >

Forest Dussault, Software Engineer - Jun 22, 2023

Introducing a new way to bring FASTQ files to the Gencove platform

We’re excited to announce that we are introducing a new feature that will make bringing users’ FASTQ files onto Gencove’s platform easier than ever.

Read More >

Oliver Arnstein, Software Engineer - Jun 15, 2023

Increasing insight into subscription notification history

We're pleased to announce a new feature on Gencove's web interface that now allows users to see a detailed list of notifications sent by a subscription

Read More >

Jeremy Li - Mar 23, 2023

An evaluation of imputation accuracy in a recently released open-access genomic dataset using low-pass sequencing

In this blog post, we describe some imputation performance benchmarks for a recently released haplotype reference panel from the Martin Lab comprising haplotypes from high-depth sequence data from the 1000 Genomes project and the Human Genome Diversity Project and compare them against corresponding benchmarks for the New York Genome Center's resequencing effort of the 1000 Genomes project.

Read More >

Angie Mosquera, Software Engineer - Mar 21, 2023

User-customizable project configurations

We are pleased to announce a new feature that allows users to customize project configurations on the Gencove platform and provides our users with greater control over their projects.

Read More >

Mamad Ahangari, Data Scientist - Mar 13, 2023

Low pass sequencing plus imputation in cattle outperforms imputation from genotyping arrays

Over the past decade, the cost of genome sequencing has significantly decreased, leading to a rise in popularity of alternative sequencing methods such as low-pass whole genome sequencing instead of genotyping arrays. To meet this demand, at Gencove, we offer a cost-effective solution for generating genome-wide information by providing low-pass whole genome sequencing plus imputation as a high-throughput alternative to genotyping arrays. Our previous research has already established that low-pass whole genome sequencing outperforms traditional genotyping arrays in terms of imputation in humans (Li et al., 2021). In this blog post, we describe the results of a recent experiment where we demonstrate that imputation using low-pass whole genome sequencing is also superior to genotyping arrays in cattle.

Read More >

Joe Pickrell, CEO - Jan 01, 2023

2022 Gencove year in review


Read More >

Maximillian Rozenblum, Applied Bioinformatics Engineer - Nov 10, 2022

New species: salmon

New pipeline available: salmon

Read More >

Zlatko Mašek - Nov 03, 2022

Importing samples from existing projects

Samples already on the Gencove platform can now be easily reprocessed using a different project configuration.

Read More >

Forest Dussault, Software Engineer - Nov 01, 2022

Processing deep sequencing data with the Gencove platform

To help move towards Gencove’s vision of ubiquitous sequencing, we’re happy to announce support for our deep whole genome sequencing (WGS) pipeline!

Read More >

David Neuman, Head of Plant and Animal Genomics Sales - Aug 25, 2022

A Genotyping Platform that Changes with Your Breeding Program

Invest in a genotyping solution that changes with your breeding program. The Gencove platform ensures backward compatibility, adaptability to new markers and reference genomes, additional analyses, and continual innovation.

Read More >